3Moguilewsky M, Philibert D. Biochemical profile of RU486. The antiprogestin steoid RU486 in human fertility control[M].New York: Plenum Press, 1995.87-97.
4McDonnell DP, Goldman ME. RU486 exerts antiestrgenic activities through a novel progesterone receptor A form mediated mechanism[J] .J Biol Chem, 1994,269:11945-11949.
5Sasaki H. Aromatase activites of endometrial carcinomas and both basic and clinical analyses of endometrial hyperplasia as a premalignant disease [J]. Nippon Sanka Fujinkai Zasshi,1993,45:763-775.
6Slayden OD,Nayak NR,Burton KA,et al.Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium [J]. J Clin Endocrinol Metab, 2001,86:2668-2679.
7Chwalisz K, Brenner RM, Fuhrmann UU,et al. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium review[J]. Steroids,2000,65:741-751.
8Han S,Sidell N.RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kappa B signaling pathway[J] .J Clin Endocrinol Metab,2003,88:713-719.
9Murphy AA, Kettel LM, Morales AJ, et al. Endometrial effects of long-term low-dose administration of RU486 [J].Fertil Stril, 1995,63: 761-766.
10Newfield RS, Spitz IM, Isacson C, et al. Long-term mifepristerone(RU486) therapy resulting in massive benign endometrial hyperplasia[J]. Clin Endo Crinol,2001,54:399-404.
